Methylphenidate's mechanism of action involves

• A. Inhibits acetylcholinesterase
• B. Blocks GABA receptors
• C. Modulates serotonergic pathways by affecting dopamine transport
• D. Activates NMDA receptors

Answer: (C)

Methylphenidate increases brain monoamines by blocking their reuptake, especially dopamine and norepinephrine, which boosts attention and executive function. By inhibiting the dopamine transporter (and also the norepinephrine transporter), it raises extracellular dopamine in key areas like the prefrontal cortex, supporting improved focus and task control. This action aligns with the idea of modulating dopaminergic pathways through dopamine transport inhibition, and because the brain’s monoamine systems are interconnected, there can be downstream effects on other pathways, including serotonin, though the primary and most direct effect is on dopamine transport. The other options describe mechanisms not characteristic of this drug: acetylcholinesterase inhibition affects cholinergic signaling, GABA receptor blockade would increase excitation via inhibitory control loss, and NMDA receptor activation engages glutamatergic signaling in entirely different ways.